The therapeutic significance of the blockade of IL-6 production or IL-6 signalling, which includes trans-signaling through the IL-1–IL-6 cascade or sIL-6R, in the cancer microenvironment remains to be clarified in future investigations. Here, IL6 is linked to cancer.